multi-epitope melanoma peptide vaccine [clinicaltrials_resource:6ef878c5623308e6f238467614a0c17d]
Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma [clinicaltrials:NCT00089193]Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery [clinicaltrials:NCT00089206]Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma [clinicaltrials:NCT00118313]
intervention [clinicaltrials_vocabulary:intervention]
multi-epitope melanoma peptide vaccine [clinicaltrials_resource:6ef878c5623308e6f238467614a0c17d]
Bio2RDF identifier
6ef878c5623308e6f238467614a0c17d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6ef878c5623308e6f238467614a0c17d
intervention name [clinicaltrials_vocabulary:intervention-name]
multi-epitope melanoma peptide vaccine
identifier
clinicaltrials_resource:6ef878c5623308e6f238467614a0c17d
title
multi-epitope melanoma peptide vaccine
@en
type
label
multi-epitope melanoma peptide ...... 878c5623308e6f238467614a0c17d]
@en